Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The adenomatous polyposis coli (APC) gene is mutated in
familial adenomatous polyposis
and in most sporadic colorectal tumors. During both embryonic and postnatal periods, APC is widely expressed in a variety of tissues, including the brain and gastrointestinal tract. The APC gene product (APC) is a large multidomain protein consisting of 2843 amino acids. APC downregulates the Wnt signaling pathway through its binding to beta-catenin and Axin. Most mutated APC proteins in colorectal tumors lack the beta-catenin-binding regions and fail to inhibit Wnt signaling, leading to the overproliferation of tumor cells. Several mouse models (APC580D, APCDelta716, APC1309, APCMin, APC1638T) have been established to investigate carcinogenesis caused by APC mutations. APC also binds to APC-stimulated guanine nucleotide exchange factor, the
kinesin
superfamily-associated protein 3, IQGAP1, microtubules, EB1, and discs large (DLG). APC has both nuclear localization signals and nuclear export signals in its molecule, suggesting its occasional nuclear localization and export of beta-catenin from the nucleus. APC is highly expressed in the intestinal and colorectal epithelia and may be involved in homeostasis of the enterocyte renewal phenomena, in which proliferation, migration, differentiation, and apoptosis are highly regulated both temporally and spatially. Through the many binding proteins mentioned, APC can exert multiple functions involved in epithelial homeostasis.
...
PMID:Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia. 1757 42
Familial adenomatous polyposis
(
FAP
) is an autosomal dominant form of intestinal polyposis and colorectal cancer caused by germ-line mutations in the adenomatous polyposis coli (APC) gene. The term Gardner's syndrome is used to describe extracolonic manifestations, such as osteomas, skin cysts, congenital hypertrophy of the retinal pigmented epithelium (CHRPE), and desmoid tumours (aggressive fibromatosis), that are especially prominent in families with
FAP
. We postulate that a ciliary dysfunction is the underlying pathogenetic mechanism of extraintestinal manifestations in patients with
FAP
. This postulation is based on the presence of common clinical manifestations (ie, cysts, retinal abnormalities, and fibrosis) in Gardner's syndrome and cilia-related disorders. Additionally, both APC and the cilia have degradation of beta-catenin as the common downstream target in the Wnt-signalling pathway. Mutations in APC causing Gardner's syndrome are clustered in a region encoding a series of amino-acid repeats responsible for the binding to beta-catenin. Proofs of principle that beta-catenin could be the key mediator of the ciliary disorder also rely in the findings that overexpression of beta-catenin induces polycystic kidney disease, and CHRPE phenotypes in animal models. Other candidates for the common link between Gardner's syndrome and cilia-related disorders are the APC-binding proteins: end-binding protein 1 (EB1) and
kinesin
-family-member 3a (KIF3a), both of which are ciliary proteins involved in intraflagellar transport. Finally, pathogenetic similarities between some ciliopathies and extraintestinal tumours in
FAP
suggest a cilia defect. Understanding extracolonic manifestations in the context of
FAP
as a ciliary disorder might add new therapeutic options for patients with Gardner's syndrome.
...
PMID:Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder. 1957 2
Microtubules and their associated proteins (MAPs) underpin the polarity of specialised cells.
Adenomatous polyposis coli
(
APC
) is one such MAP with a multifunctional agenda that requires precise intracellular localisations. Although
APC
has been found to associate with kinesin-2 subfamily members, the exact mechanism for the peripheral localization of
APC
remains unclear. Here we show that the heavy chain of
kinesin
-1 directly interacts with the
APC
C-terminus, contributing to the peripheral localisation of
APC
in fibroblasts. In rat hippocampal neurons the
kinesin
-1 binding domain of
APC
is required for its axon tip enrichment. Moreover, we demonstrate that
APC
requires interactions with both kinesin-2 and
kinesin
-1 for this localisation. Underlining the importance of the
kinesin
-1 association, neurons expressing
APC
lacking
kinesin
-1-binding domain have shorter axons. The identification of this novel
kinesin
-1-
APC
interaction highlights the complexity and significance of
APC
localisation in neurons.
...
PMID:Tumour Suppressor Adenomatous Polyposis Coli (APC) localisation is regulated by both Kinesin-1 and Kinesin-2. 2727 32